EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access · CC BY-NC 4.0

Tofacitinib in older patients with ulcerative colitis: balancing efficacy and safety

Yoon Suk Jung

Intestinal Research · 30.04.2026 · 24 (2) · 193-194

DOI: 10.5217/ir.2026.00070 ↗

Kurz gefasst

Editorial in der Zeitschrift Intestinal Research, erschienen am 30.04.2026. Verfasst von Yoon Suk Jung. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

Zitieren

APA

Jung, Y. S. (2026). Tofacitinib in older patients with ulcerative colitis: balancing efficacy and safety. Intestinal Research, 24(2), 193-194. https://doi.org/10.5217/ir.2026.00070

Vancouver

Jung YS. Tofacitinib in older patients with ulcerative colitis: balancing efficacy and safety. Intestinal Research. 2026;24(2):193-194. doi:10.5217/ir.2026.00070

BibTeX
@article{Jung2026,
  author = {Jung, Yoon Suk},
  title = {Tofacitinib in older patients with ulcerative colitis: balancing efficacy and safety},
  journal = {Intestinal Research},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {193--194},
  doi = {10.5217/ir.2026.00070}
}
Kostenlos starten →